Does TECLISTAMAB-CQYV Cause Neuropathy peripheral? 36 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Neuropathy peripheral have been filed in association with TECLISTAMAB-CQYV. This represents 2.3% of all adverse event reports for TECLISTAMAB-CQYV.
36
Reports of Neuropathy peripheral with TECLISTAMAB-CQYV
2.3%
of all TECLISTAMAB-CQYV reports
2
Deaths
5
Hospitalizations
How Dangerous Is Neuropathy peripheral From TECLISTAMAB-CQYV?
Of the 36 reports, 2 (5.6%) resulted in death, 5 (13.9%) required hospitalization, and 1 (2.8%) were considered life-threatening.
Is Neuropathy peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB-CQYV. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB-CQYV Cause?
Cytokine release syndrome (406)
Immune effector cell-associated neurotoxicity syndrome (153)
Off label use (122)
Death (116)
Plasma cell myeloma (96)
Infection (83)
Neutropenia (74)
Fatigue (72)
Pyrexia (67)
Covid-19 (64)
What Other Drugs Cause Neuropathy peripheral?
LENALIDOMIDE (10,215)
BORTEZOMIB (4,067)
OXALIPLATIN (3,662)
DEXAMETHASONE (3,543)
PACLITAXEL (3,508)
LEVOFLOXACIN (2,619)
CIPROFLOXACIN (2,607)
FLUOROURACIL (2,605)
CYCLOPHOSPHAMIDE (2,565)
POMALIDOMIDE (2,382)
Which TECLISTAMAB-CQYV Alternatives Have Lower Neuropathy peripheral Risk?
TECLISTAMAB-CQYV vs TEDIZOLID
TECLISTAMAB-CQYV vs TEDUGLUTIDE
TECLISTAMAB-CQYV vs TEDUGLUTIDE\WATER
TECLISTAMAB-CQYV vs TEGAFUR
TECLISTAMAB-CQYV vs TEGAFUR\URACIL